-+ 0.00%
-+ 0.00%
-+ 0.00%

Scilex unit ACEA Therapeutics agrees to sell ACEA Pharma to Phoenix Asia for $1 billion

PUBT·05/05/2026 17:04:06
Listen to the news
Scilex unit ACEA Therapeutics agrees to sell ACEA Pharma to Phoenix Asia for $1 billion
  • Scilex indirect subsidiary ACEA Therapeutics agreed to sell 100% of ACEA Pharma to Phoenix Asia Holdings in exchange for 100,000,000 newly issued Phoenix ordinary shares priced at USD 10 each, valuing consideration at USD 1 billion.
  • Phoenix plans to rename itself ACEA Pharma, with common stock expected to be listed on Nasdaq.
  • Closing is targeted by end of Q2 2026, with ACEA Therapeutics expected to own about 82% of go-forward company upon completion.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Scilex Holding Company published the original content used to generate this news brief on May 05, 2026, and is solely responsible for the information contained therein.